Tuesday, August 6, 2019

Elanco buys Montreal vaccine company

Elanco is paying $78.5 million to buy Prevtec Microbia of Montreal, a start-up company that developed a vaccine to counter weaning-pig scours.

It is coming to market at a time when antibiotics are falling out of favour. In Europe they are banned, so vaccines are popular with hog producers.